Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 111

Results For "ABI"

3129 News Found

Agilent announces new ProteoAnalyzer system
News | January 17, 2024

Agilent announces new ProteoAnalyzer system

Automated parallel capillary electrophoresis system simplifies protein analysis


INVpack presents microdosing precision in pharma and nutritional packaging for India
News | January 16, 2024

INVpack presents microdosing precision in pharma and nutritional packaging for India

Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets


Lupin Life hosted Second Edition of Aptivate Champion Run for Kids
News | January 15, 2024

Lupin Life hosted Second Edition of Aptivate Champion Run for Kids

The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars


ARTBIO and PharmaLogic inks supply agreement for Lead-212 based Therapeutic Candidate for  treatment of prostate cancer
Supply Chain | January 15, 2024

ARTBIO and PharmaLogic inks supply agreement for Lead-212 based Therapeutic Candidate for treatment of prostate cancer

PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York


Briefs: Venus Remedies and Shivalik Rasayan
News | January 13, 2024

Briefs: Venus Remedies and Shivalik Rasayan

Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA


Tata Consumer Products to acquire Organic India
News | January 13, 2024

Tata Consumer Products to acquire Organic India

A 'better for you' organic brand spanning Food & Beverages and Nutraceutical categories


NITI Aayog organises workshop on ‘Strengthening Mental Health Services and Care in India’
Policy | January 12, 2024

NITI Aayog organises workshop on ‘Strengthening Mental Health Services and Care in India’

The workshop was conducted as a part of the NITI–State workshop series


Shanghai Argo announces multi-program RNAi licenses with Novartis
News | January 11, 2024

Shanghai Argo announces multi-program RNAi licenses with Novartis

Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.


USFDA accepts sBLA of TIVDAK for priority review for patients with metastatic cervical cancer
Drug Approval | January 10, 2024

USFDA accepts sBLA of TIVDAK for priority review for patients with metastatic cervical cancer

Submission based on positive results from global phase 3 study demonstrating overall survival benefit of TIVDAK over chemotherapy